Annual Report

Overview

The report describes a challenging 2013, with Group sales declining 2%, while acquisitions expanded the Therapy segment’s US presence and added an Austrian radiopharma business. It reports that approximately 140,000 patients were treated through the Therapy segment and that the year’s innovation ratio reached 21%.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2013
Period: 1 January 2013 – 31 December 2013
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services